Auxogyn Receives $18,000,000 Series B Financing Round

  • Feed Type
  • Date
    6/6/2012
  • Company Name
    Auxogyn
  • Mailing Address
    1490 O’Brien Drive Menlo Park, CA 94025
  • Company Description
    Auxogyn – Advancing women’s reproductive health through novel scientific and clinical knowledge of early human developmental biology.
  • Website
    http://www.auxogyn.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $18,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The proceeds will be used to support regulatory clearance and commercial launch of Auxogyn’s Early Embryo Viability Assessment, Eeva, a non-invasive test designed to provide objective information regarding the viability of embryos during in vitro fertilization (IVF) procedures.
  • M&A Terms
  • Venture Investor
    SR One
  • Venture Investor
    Kleiner Perkins Caufield & Byers
  • Venture Investor
    TPG Biotech
  • Venture Investor
    Merck Serono Ventures

By posting a comment, you agree to our terms and conditions.